MDT- Medtronic plc
Healthcare · Medical Devices
Price & Performance
Performance
Analysis & Verdict
Analyst Ratings
BuyWall Street consensus from 25 analysts
12-Month Price Target
$104.76
Based on analyst estimates; price targets are opinions, not guarantees.
Fair Value Estimates
Current price: $90.96
Graham Number
√(22.5 × EPS × Book Value)
$59.87
Benjamin Graham's intrinsic value formula. Assumes a fair stock trades at no more than 22.5× the product of EPS and book value per share.
Bazin Ceiling Price
Avg. Annual DPS (5Y) ÷ 6%
$45.03
Décio Bazin's dividend-based ceiling. The max price you should pay so that dividends alone deliver at least 6% annual yield on your cost basis.
These are simplified estimates. Not financial advice.
Buy & Hold Checklist
Quality criteria for long-term holding
9/10
90% score
Pays dividends
15Y hist.15+ years of dividend history
Dividend consistency (5Y+)
15 yrsUninterrupted dividend payments for at least 5 years
ROE above 10%
10.6%Return on equity - measures how efficiently capital is used
Positive profit margin
13.9%Net profit margin must be positive - company earns more than it spends
Revenue growth (annual)
+13.7%Annual revenue must be growing compared to the prior year
Earnings growth (annual)
+40.7%Annual earnings must be growing compared to the prior year
Debt/Equity below 2×
55.37×Low financial leverage reduces risk of distress
Current ratio above 1
2.07×Short-term assets must cover short-term liabilities
Daily liquidity above $5M
$735M/dayHigh trading volume ensures easy entry and exit
Dividend yield above 0%
3.17%Stock must distribute income to shareholders
Financials
Revenue & Results
Key Statistics
Earnings
Next Earnings
Nov 17, 2026
66
days
EPS (TTM)
$4.06
P/E (TTM)
22.4
Fwd P/E
14.2
SEC Filings & Reported Financials
Earnings History
SEC EDGAR · official filings
SEC Filings
Official EDGAR documents
Insider Transactions
SEC Form 4 · officers, directors & 10% owners
Dividends & Income
Dividends
Current DY
3.17%
5Y Avg Annual
$2.4940
Last Payment
$0.7200
Ex-Date
06/26/2026
Annual dividends paid per share
| Ex-Date | Payment | Amount | Est. DY |
|---|---|---|---|
Latest06/26/2026 | 07/17/2026 | $0.7200 | 3.17% |
03/27/2026 | 04/17/2026 | $0.7100 | 3.12% |
12/26/2025 | 01/16/2026 | $0.7100 | 3.12% |
09/26/2025 | 10/17/2025 | $0.7100 | 3.12% |
06/27/2025 | 07/18/2025 | $0.7100 | 3.12% |
03/28/2025 | 04/18/2025 | $0.7000 | 3.08% |
12/27/2024 | 01/17/2025 | $0.7000 | 3.08% |
09/27/2024 | 10/18/2024 | $0.7000 | 3.08% |
Magic Number
Shares needed to self-fund your next purchase
$90.96
Price
$0.7200
Last div. (quarterly)
127
shares
Own 127 MDT shares ($11,551.92) and each quarterly dividend pays for 1 new share - the snowball runs on its own.
Investment target
$11,551.92
New shares / year
+4 shares
Dividend Calculator
3.17% yieldEstimate MDT dividend income at the current rate.
Per year
$316.62
Per month
$26.39
≈ 109.9 shares at $2.88/share a year. Estimate only - dividends can be cut or raised.
Tools & Simulators
MDT vs Peers, Indexes & Commodities
?Click a card below to plot it on the chart
Loading history…
Parameters
Final value
$426,404.61
Total invested
$130,000.00
Total interest
$296,404.61
Balance over time
Period breakdown
| Period | Balance | Invested | Interest |
|---|---|---|---|
| Start | $10,000.00 | $10,000.00 | $0.00 |
| Year 1 | $17,270.27 | $16,000.00 | $1,270.27 |
| Year 2 | $25,267.56 | $22,000.00 | $3,267.56 |
| Year 3 | $34,064.59 | $28,000.00 | $6,064.59 |
| Year 4 | $43,741.32 | $34,000.00 | $9,741.32 |
| Year 5 | $54,385.72 | $40,000.00 | $14,385.72 |
| Year 6 | $66,094.55 | $46,000.00 | $20,094.55 |
| Year 7 | $78,974.28 | $52,000.00 | $26,974.28 |
| Year 8 | $93,141.97 | $58,000.00 | $35,141.97 |
| Year 9 | $108,726.44 | $64,000.00 | $44,726.44 |
| Year 10 | $125,869.35 | $70,000.00 | $55,869.35 |
| Year 11 | $144,726.56 | $76,000.00 | $68,726.56 |
| Year 12 | $165,469.48 | $82,000.00 | $83,469.48 |
| Year 13 | $188,286.70 | $88,000.00 | $100,286.70 |
| Year 14 | $213,385.63 | $94,000.00 | $119,385.63 |
| Year 15 | $240,994.47 | $100,000.00 | $140,994.47 |
| Year 16 | $271,364.18 | $106,000.00 | $165,364.18 |
| Year 17 | $304,770.87 | $112,000.00 | $192,770.87 |
| Year 18 | $341,518.22 | $118,000.00 | $223,518.22 |
| Year 19 | $381,940.31 | $124,000.00 | $257,940.31 |
| Year 20 | $426,404.61 | $130,000.00 | $296,404.61 |
What is compound interest?
Compound interest means that the interest you earn in one period is added to your principal, so in the next period you earn interest on a larger base. This creates exponential growth: the longer your time horizon, the more dramatic the effect.
Which rate should I use?
The S&P 500 has historically returned ~10%/year before inflation over long periods - use this for an all-equity US index fund scenario. A balanced growth portfolio (stocks + bonds) is closer to 7%. High-yield savings accounts (HYSA) are currently paying around 4-5% with FDIC insurance and zero market risk. Bonds historically return ~4% annualized.
Formula used
FV = PV × (1+r)^n + PMT × ((1+r)^n − 1) / rwhere r is the monthly rate, n is the number of months, PV is the initial investment, and PMT is the monthly contribution. Annual rates are converted to monthly viar = (1 + annual%)^(1/12) − 1.
For educational purposes only. Not financial advice. Past returns do not guarantee future results.
Discussion
Sign in to join the discussionSign inLoading…
Discover
Related Assets
Healthcare
Related Articles
About Medtronic plc
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.
Stock Market ROI Pro
All features, zero ads- web & app
Unlock every feature, ad-free, across our website and iOS app.
Medtronic plc (MDT) stock trades at $90.96, down 0.72% on the day. With a market capitalization of $116.35 billion, MDT is a large-cap healthcare stock. It trades at a price-to-earnings (P/E) ratio of 22.4, a forward P/E of 14.2 and earnings per share (EPS) of $4.06. Over the most recent period the company reported 14% year-over-year revenue growth and a net profit margin of 13.9%. Below you'll find MDT's full fundamentals, fair-value estimates, dividend history, earnings and our buy, hold or avoid verdict for 2026.
MDT - Frequently Asked Questions
Is Medtronic plc (MDT) a good stock to buy in 2026?
Medtronic plc (MDT) shows strengths such as revenue growth of 14%, while risks include high leverage (debt/equity of 55.4). Whether MDT is a good buy in 2026 depends on your time horizon and risk tolerance - review the full bull case, bear case and fair-value estimates above. This is informational analysis, not financial advice.
What is MDT's stock price today?
Medtronic plc (MDT) trades at $90.96, down 0.72% on the session. Prices on this page update throughout the trading day.
Does MDT pay a dividend?
Yes. Medtronic plc pays an annual dividend of $2.88 per share, a dividend yield of 3.17%. The most recent ex-dividend date was September 25, 2026. Its payout ratio is about 70% of earnings.
Is MDT overvalued?
With a P/E ratio of 22.4×, MDT trades at a roughly market-average valuation for the healthcare sector. Its PEG ratio is 1.65. See the Fair Value Estimates section above for Graham Number and dividend-based price targets.
What is MDT's market cap?
Medtronic plc (MDT) has a market capitalization of $116.35 billion, classifying it as a large-cap stock in the Healthcare sector.
Disclaimer: This page - including any buy/hold/avoid view, fair value or price estimate - is generated from market data for informational and educational purposes only and does not constitute financial, investment or trading advice. Data may be delayed or inaccurate. Always do your own research and consult a licensed financial advisor before making any investment decision.